More

    Station

    COVID-19: Entering Phase 2: Moderna Therapeutics Races Vaccine

    Moderna Therapeutics, a Cambridge-based biotechnology company, is at the forefront of coronavirus vaccine development. The company recently received FDA approval to move onto Phase 2 of vaccine testing, in addition to $500 million in grants.

    Stay on op - Ge the daily news in your inbox

    Tag Cloud Template - Tech News Pro